Global Cell and Gene Therapy Supply, Demand and Key Producers, 2026-2032
The global Cell and Gene Therapy market size is expected to reach $ 5826 million by 2032, rising at a market growth of 6.7% CAGR during the forecast period (2026-2032).
Cell and Gene Therapy is a revolutionary medical technology that treats or cures diseases by modifying or manipulating human genes. Its core lies in intervening at the root causes of genetic defects, cancer, and chronic diseases. This therapy is mainly divided into two categories: gene therapy focuses on delivering functionally normal genes into the patient's body via viral or non-viral vectors to replace or compensate for defective/abnormal genes, or to silence the expression of harmful genes; cell therapy involves modifying, activating, or expanding autologous or allogeneic live cells (such as immune cells and stem cells) in vitro and then reinfusing them to rebuild immune function, repair damaged tissue, or directly kill tumors. As a cutting-edge field of precision medicine, Cell and Gene Therapy offers potential cures for many diseases that traditional therapies have failed to address.
The global cell and gene therapy market is experiencing rapid growth driven by technological breakthroughs, a surge in pipelines, and commercialization. North America and Europe, as mature markets, lead in the number of approved CAR-T therapies, AAV gene therapies, and rare disease drugs, leveraging their advanced gene-editing technologies, robust regulatory frameworks, and extensive clinical research experience. The Asia-Pacific region is the fastest-growing and most active in clinical research. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across its supply chain, is rapidly advancing autologous CAR-T, universal cell therapies, and gene-editing therapies, leading to the rapid rise of domestic innovative pharmaceutical companies. The industry as a whole is accelerating its evolution towards breakthroughs in solid tumors, universal off-the-shelf products, and in vivo gene editing.
This report studies the global Cell and Gene Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy total market, 2021-2032, (USD Million)
Global Cell and Gene Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Cell and Gene Therapy total market, key domestic companies, and share, (USD Million)
Global Cell and Gene Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Cell and Gene Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global Cell and Gene Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Cell and Gene Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc, Lonza, Charles River Laboratories, Cytiva, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, Made Scientific, AGC Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cell and Gene Therapy Market, By Region:
1. How big is the global Cell and Gene Therapy market?
2. What is the demand of the global Cell and Gene Therapy market?
3. What is the year over year growth of the global Cell and Gene Therapy market?
4. What is the total value of the global Cell and Gene Therapy market?
5. Who are the Major Players in the global Cell and Gene Therapy market?
6. What are the growth factors driving the market demand?
Cell and Gene Therapy is a revolutionary medical technology that treats or cures diseases by modifying or manipulating human genes. Its core lies in intervening at the root causes of genetic defects, cancer, and chronic diseases. This therapy is mainly divided into two categories: gene therapy focuses on delivering functionally normal genes into the patient's body via viral or non-viral vectors to replace or compensate for defective/abnormal genes, or to silence the expression of harmful genes; cell therapy involves modifying, activating, or expanding autologous or allogeneic live cells (such as immune cells and stem cells) in vitro and then reinfusing them to rebuild immune function, repair damaged tissue, or directly kill tumors. As a cutting-edge field of precision medicine, Cell and Gene Therapy offers potential cures for many diseases that traditional therapies have failed to address.
The global cell and gene therapy market is experiencing rapid growth driven by technological breakthroughs, a surge in pipelines, and commercialization. North America and Europe, as mature markets, lead in the number of approved CAR-T therapies, AAV gene therapies, and rare disease drugs, leveraging their advanced gene-editing technologies, robust regulatory frameworks, and extensive clinical research experience. The Asia-Pacific region is the fastest-growing and most active in clinical research. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across its supply chain, is rapidly advancing autologous CAR-T, universal cell therapies, and gene-editing therapies, leading to the rapid rise of domestic innovative pharmaceutical companies. The industry as a whole is accelerating its evolution towards breakthroughs in solid tumors, universal off-the-shelf products, and in vivo gene editing.
This report studies the global Cell and Gene Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy total market, 2021-2032, (USD Million)
Global Cell and Gene Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Cell and Gene Therapy total market, key domestic companies, and share, (USD Million)
Global Cell and Gene Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Cell and Gene Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global Cell and Gene Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Cell and Gene Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc, Lonza, Charles River Laboratories, Cytiva, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, Made Scientific, AGC Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cell and Gene Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Rare Diseases
- Oncology
- Hematology
- Cardiovascular
- Ophthalmology
- Neurology
- Others
- Autologous Cell Therapy
- Universal Cell Therapy
- Xenogeneic Cell Therapy
- Viral Vector Delivery
- Non-viral Vector Delivery
- Gene Editing Technology
- Others
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Contract Research Organizations (CROs)
- Hospital
- Others
- Amgen Inc.
- Dendreon Pharmaceuticals LLC.
- Fibrocell Science, Inc
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- Made Scientific
- AGC Biologics
- Pfizer CentreOne
- Samsung Biologics
- Kite Pharma, Inc.
- Kolon TissueGene, Inc.
- Novartis AG
1. How big is the global Cell and Gene Therapy market?
2. What is the demand of the global Cell and Gene Therapy market?
3. What is the year over year growth of the global Cell and Gene Therapy market?
4. What is the total value of the global Cell and Gene Therapy market?
5. Who are the Major Players in the global Cell and Gene Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell and Gene Therapy Introduction
1.2 World Cell and Gene Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cell and Gene Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.3 China Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.4 Europe Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.5 Japan Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.8 India Based Company Cell and Gene Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy Consumption Value (2021-2032)
2.2 World Cell and Gene Therapy Consumption Value by Region
2.2.1 World Cell and Gene Therapy Consumption Value by Region (2021-2026)
2.2.2 World Cell and Gene Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States Cell and Gene Therapy Consumption Value (2021-2032)
2.4 China Cell and Gene Therapy Consumption Value (2021-2032)
2.5 Europe Cell and Gene Therapy Consumption Value (2021-2032)
2.6 Japan Cell and Gene Therapy Consumption Value (2021-2032)
2.7 South Korea Cell and Gene Therapy Consumption Value (2021-2032)
2.8 ASEAN Cell and Gene Therapy Consumption Value (2021-2032)
2.9 India Cell and Gene Therapy Consumption Value (2021-2032)
3 WORLD CELL AND GENE THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy in 2025
3.3 Cell and Gene Therapy Company Evaluation Quadrant
3.4 Cell and Gene Therapy Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy Market: Region Footprint
3.4.2 Cell and Gene Therapy Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cell and Gene Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cell and Gene Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based Cell and Gene Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy Revenue, (2021-2026)
4.4 China Based Companies Cell and Gene Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based Cell and Gene Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy Revenue, (2021-2026)
4.5 Rest of World Based Cell and Gene Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cell and Gene Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Rare Diseases
5.2.2 Oncology
5.2.3 Hematology
5.2.4 Cardiovascular
5.2.5 Ophthalmology
5.2.6 Neurology
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy Market Size by Type (2021-2026)
5.3.2 World Cell and Gene Therapy Market Size by Type (2027-2032)
5.3.3 World Cell and Gene Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CELL SOURCE
6.1 World Cell and Gene Therapy Market Size Overview by Cell Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Source
6.2.1 Autologous Cell Therapy
6.2.2 Universal Cell Therapy
6.2.3 Xenogeneic Cell Therapy
6.3 Market Segment by Cell Source
6.3.1 World Cell and Gene Therapy Market Size by Cell Source (2021-2026)
6.3.2 World Cell and Gene Therapy Market Size by Cell Source (2027-2032)
6.3.3 World Cell and Gene Therapy Market Size Market Share by Cell Source (2027-2032)
7 MARKET ANALYSIS BY TECHNOLOGY
7.1 World Cell and Gene Therapy Market Size Overview by Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Technology
7.2.1 Viral Vector Delivery
7.2.2 Non-viral Vector Delivery
7.2.3 Gene Editing Technology
7.2.4 Others
7.3 Market Segment by Technology
7.3.1 World Cell and Gene Therapy Market Size by Technology (2021-2026)
7.3.2 World Cell and Gene Therapy Market Size by Technology (2027-2032)
7.3.3 World Cell and Gene Therapy Market Size Market Share by Technology (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cell and Gene Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 Research and Academic Institutions
8.2.3 Contract Research Organizations (CROs)
8.2.4 Hospital
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Cell and Gene Therapy Market Size by Application (2021-2026)
8.3.2 World Cell and Gene Therapy Market Size by Application (2027-2032)
8.3.3 World Cell and Gene Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Amgen Inc.
9.1.1 Amgen Inc. Details
9.1.2 Amgen Inc. Major Business
9.1.3 Amgen Inc. Cell and Gene Therapy Product and Services
9.1.4 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Amgen Inc. Recent Developments/Updates
9.1.6 Amgen Inc. Competitive Strengths & Weaknesses
9.2 Dendreon Pharmaceuticals LLC.
9.2.1 Dendreon Pharmaceuticals LLC. Details
9.2.2 Dendreon Pharmaceuticals LLC. Major Business
9.2.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Services
9.2.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Dendreon Pharmaceuticals LLC. Recent Developments/Updates
9.2.6 Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
9.3 Fibrocell Science, Inc
9.3.1 Fibrocell Science, Inc Details
9.3.2 Fibrocell Science, Inc Major Business
9.3.3 Fibrocell Science, Inc Cell and Gene Therapy Product and Services
9.3.4 Fibrocell Science, Inc Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Fibrocell Science, Inc Recent Developments/Updates
9.3.6 Fibrocell Science, Inc Competitive Strengths & Weaknesses
9.4 Lonza
9.4.1 Lonza Details
9.4.2 Lonza Major Business
9.4.3 Lonza Cell and Gene Therapy Product and Services
9.4.4 Lonza Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Lonza Recent Developments/Updates
9.4.6 Lonza Competitive Strengths & Weaknesses
9.5 Charles River Laboratories
9.5.1 Charles River Laboratories Details
9.5.2 Charles River Laboratories Major Business
9.5.3 Charles River Laboratories Cell and Gene Therapy Product and Services
9.5.4 Charles River Laboratories Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Charles River Laboratories Recent Developments/Updates
9.5.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.6 Cytiva
9.6.1 Cytiva Details
9.6.2 Cytiva Major Business
9.6.3 Cytiva Cell and Gene Therapy Product and Services
9.6.4 Cytiva Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Cytiva Recent Developments/Updates
9.6.6 Cytiva Competitive Strengths & Weaknesses
9.7 Catalent Biologics
9.7.1 Catalent Biologics Details
9.7.2 Catalent Biologics Major Business
9.7.3 Catalent Biologics Cell and Gene Therapy Product and Services
9.7.4 Catalent Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent Biologics Recent Developments/Updates
9.7.6 Catalent Biologics Competitive Strengths & Weaknesses
9.8 FUJIFILM Diosynth Biotechnologies
9.8.1 FUJIFILM Diosynth Biotechnologies Details
9.8.2 FUJIFILM Diosynth Biotechnologies Major Business
9.8.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product and Services
9.8.4 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
9.8.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
9.9 Made Scientific
9.9.1 Made Scientific Details
9.9.2 Made Scientific Major Business
9.9.3 Made Scientific Cell and Gene Therapy Product and Services
9.9.4 Made Scientific Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Made Scientific Recent Developments/Updates
9.9.6 Made Scientific Competitive Strengths & Weaknesses
9.10 AGC Biologics
9.10.1 AGC Biologics Details
9.10.2 AGC Biologics Major Business
9.10.3 AGC Biologics Cell and Gene Therapy Product and Services
9.10.4 AGC Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 AGC Biologics Recent Developments/Updates
9.10.6 AGC Biologics Competitive Strengths & Weaknesses
9.11 Pfizer CentreOne
9.11.1 Pfizer CentreOne Details
9.11.2 Pfizer CentreOne Major Business
9.11.3 Pfizer CentreOne Cell and Gene Therapy Product and Services
9.11.4 Pfizer CentreOne Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Pfizer CentreOne Recent Developments/Updates
9.11.6 Pfizer CentreOne Competitive Strengths & Weaknesses
9.12 Samsung Biologics
9.12.1 Samsung Biologics Details
9.12.2 Samsung Biologics Major Business
9.12.3 Samsung Biologics Cell and Gene Therapy Product and Services
9.12.4 Samsung Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Samsung Biologics Recent Developments/Updates
9.12.6 Samsung Biologics Competitive Strengths & Weaknesses
9.13 Kite Pharma, Inc.
9.13.1 Kite Pharma, Inc. Details
9.13.2 Kite Pharma, Inc. Major Business
9.13.3 Kite Pharma, Inc. Cell and Gene Therapy Product and Services
9.13.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Kite Pharma, Inc. Recent Developments/Updates
9.13.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
9.14 Kolon TissueGene, Inc.
9.14.1 Kolon TissueGene, Inc. Details
9.14.2 Kolon TissueGene, Inc. Major Business
9.14.3 Kolon TissueGene, Inc. Cell and Gene Therapy Product and Services
9.14.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Kolon TissueGene, Inc. Recent Developments/Updates
9.14.6 Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
9.15 Novartis AG
9.15.1 Novartis AG Details
9.15.2 Novartis AG Major Business
9.15.3 Novartis AG Cell and Gene Therapy Product and Services
9.15.4 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Novartis AG Recent Developments/Updates
9.15.6 Novartis AG Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cell and Gene Therapy Industry Chain
10.2 Cell and Gene Therapy Upstream Analysis
10.3 Cell and Gene Therapy Midstream Analysis
10.4 Cell and Gene Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Cell and Gene Therapy Introduction
1.2 World Cell and Gene Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cell and Gene Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.3 China Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.4 Europe Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.5 Japan Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company Cell and Gene Therapy Revenue (2021-2032)
1.3.8 India Based Company Cell and Gene Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy Consumption Value (2021-2032)
2.2 World Cell and Gene Therapy Consumption Value by Region
2.2.1 World Cell and Gene Therapy Consumption Value by Region (2021-2026)
2.2.2 World Cell and Gene Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States Cell and Gene Therapy Consumption Value (2021-2032)
2.4 China Cell and Gene Therapy Consumption Value (2021-2032)
2.5 Europe Cell and Gene Therapy Consumption Value (2021-2032)
2.6 Japan Cell and Gene Therapy Consumption Value (2021-2032)
2.7 South Korea Cell and Gene Therapy Consumption Value (2021-2032)
2.8 ASEAN Cell and Gene Therapy Consumption Value (2021-2032)
2.9 India Cell and Gene Therapy Consumption Value (2021-2032)
3 WORLD CELL AND GENE THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy in 2025
3.3 Cell and Gene Therapy Company Evaluation Quadrant
3.4 Cell and Gene Therapy Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy Market: Region Footprint
3.4.2 Cell and Gene Therapy Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cell and Gene Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cell and Gene Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based Cell and Gene Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy Revenue, (2021-2026)
4.4 China Based Companies Cell and Gene Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based Cell and Gene Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy Revenue, (2021-2026)
4.5 Rest of World Based Cell and Gene Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cell and Gene Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Rare Diseases
5.2.2 Oncology
5.2.3 Hematology
5.2.4 Cardiovascular
5.2.5 Ophthalmology
5.2.6 Neurology
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy Market Size by Type (2021-2026)
5.3.2 World Cell and Gene Therapy Market Size by Type (2027-2032)
5.3.3 World Cell and Gene Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CELL SOURCE
6.1 World Cell and Gene Therapy Market Size Overview by Cell Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Source
6.2.1 Autologous Cell Therapy
6.2.2 Universal Cell Therapy
6.2.3 Xenogeneic Cell Therapy
6.3 Market Segment by Cell Source
6.3.1 World Cell and Gene Therapy Market Size by Cell Source (2021-2026)
6.3.2 World Cell and Gene Therapy Market Size by Cell Source (2027-2032)
6.3.3 World Cell and Gene Therapy Market Size Market Share by Cell Source (2027-2032)
7 MARKET ANALYSIS BY TECHNOLOGY
7.1 World Cell and Gene Therapy Market Size Overview by Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Technology
7.2.1 Viral Vector Delivery
7.2.2 Non-viral Vector Delivery
7.2.3 Gene Editing Technology
7.2.4 Others
7.3 Market Segment by Technology
7.3.1 World Cell and Gene Therapy Market Size by Technology (2021-2026)
7.3.2 World Cell and Gene Therapy Market Size by Technology (2027-2032)
7.3.3 World Cell and Gene Therapy Market Size Market Share by Technology (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cell and Gene Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 Research and Academic Institutions
8.2.3 Contract Research Organizations (CROs)
8.2.4 Hospital
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Cell and Gene Therapy Market Size by Application (2021-2026)
8.3.2 World Cell and Gene Therapy Market Size by Application (2027-2032)
8.3.3 World Cell and Gene Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Amgen Inc.
9.1.1 Amgen Inc. Details
9.1.2 Amgen Inc. Major Business
9.1.3 Amgen Inc. Cell and Gene Therapy Product and Services
9.1.4 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Amgen Inc. Recent Developments/Updates
9.1.6 Amgen Inc. Competitive Strengths & Weaknesses
9.2 Dendreon Pharmaceuticals LLC.
9.2.1 Dendreon Pharmaceuticals LLC. Details
9.2.2 Dendreon Pharmaceuticals LLC. Major Business
9.2.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Services
9.2.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Dendreon Pharmaceuticals LLC. Recent Developments/Updates
9.2.6 Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
9.3 Fibrocell Science, Inc
9.3.1 Fibrocell Science, Inc Details
9.3.2 Fibrocell Science, Inc Major Business
9.3.3 Fibrocell Science, Inc Cell and Gene Therapy Product and Services
9.3.4 Fibrocell Science, Inc Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Fibrocell Science, Inc Recent Developments/Updates
9.3.6 Fibrocell Science, Inc Competitive Strengths & Weaknesses
9.4 Lonza
9.4.1 Lonza Details
9.4.2 Lonza Major Business
9.4.3 Lonza Cell and Gene Therapy Product and Services
9.4.4 Lonza Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Lonza Recent Developments/Updates
9.4.6 Lonza Competitive Strengths & Weaknesses
9.5 Charles River Laboratories
9.5.1 Charles River Laboratories Details
9.5.2 Charles River Laboratories Major Business
9.5.3 Charles River Laboratories Cell and Gene Therapy Product and Services
9.5.4 Charles River Laboratories Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Charles River Laboratories Recent Developments/Updates
9.5.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.6 Cytiva
9.6.1 Cytiva Details
9.6.2 Cytiva Major Business
9.6.3 Cytiva Cell and Gene Therapy Product and Services
9.6.4 Cytiva Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Cytiva Recent Developments/Updates
9.6.6 Cytiva Competitive Strengths & Weaknesses
9.7 Catalent Biologics
9.7.1 Catalent Biologics Details
9.7.2 Catalent Biologics Major Business
9.7.3 Catalent Biologics Cell and Gene Therapy Product and Services
9.7.4 Catalent Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent Biologics Recent Developments/Updates
9.7.6 Catalent Biologics Competitive Strengths & Weaknesses
9.8 FUJIFILM Diosynth Biotechnologies
9.8.1 FUJIFILM Diosynth Biotechnologies Details
9.8.2 FUJIFILM Diosynth Biotechnologies Major Business
9.8.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product and Services
9.8.4 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
9.8.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
9.9 Made Scientific
9.9.1 Made Scientific Details
9.9.2 Made Scientific Major Business
9.9.3 Made Scientific Cell and Gene Therapy Product and Services
9.9.4 Made Scientific Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Made Scientific Recent Developments/Updates
9.9.6 Made Scientific Competitive Strengths & Weaknesses
9.10 AGC Biologics
9.10.1 AGC Biologics Details
9.10.2 AGC Biologics Major Business
9.10.3 AGC Biologics Cell and Gene Therapy Product and Services
9.10.4 AGC Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 AGC Biologics Recent Developments/Updates
9.10.6 AGC Biologics Competitive Strengths & Weaknesses
9.11 Pfizer CentreOne
9.11.1 Pfizer CentreOne Details
9.11.2 Pfizer CentreOne Major Business
9.11.3 Pfizer CentreOne Cell and Gene Therapy Product and Services
9.11.4 Pfizer CentreOne Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Pfizer CentreOne Recent Developments/Updates
9.11.6 Pfizer CentreOne Competitive Strengths & Weaknesses
9.12 Samsung Biologics
9.12.1 Samsung Biologics Details
9.12.2 Samsung Biologics Major Business
9.12.3 Samsung Biologics Cell and Gene Therapy Product and Services
9.12.4 Samsung Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Samsung Biologics Recent Developments/Updates
9.12.6 Samsung Biologics Competitive Strengths & Weaknesses
9.13 Kite Pharma, Inc.
9.13.1 Kite Pharma, Inc. Details
9.13.2 Kite Pharma, Inc. Major Business
9.13.3 Kite Pharma, Inc. Cell and Gene Therapy Product and Services
9.13.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Kite Pharma, Inc. Recent Developments/Updates
9.13.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
9.14 Kolon TissueGene, Inc.
9.14.1 Kolon TissueGene, Inc. Details
9.14.2 Kolon TissueGene, Inc. Major Business
9.14.3 Kolon TissueGene, Inc. Cell and Gene Therapy Product and Services
9.14.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Kolon TissueGene, Inc. Recent Developments/Updates
9.14.6 Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
9.15 Novartis AG
9.15.1 Novartis AG Details
9.15.2 Novartis AG Major Business
9.15.3 Novartis AG Cell and Gene Therapy Product and Services
9.15.4 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Novartis AG Recent Developments/Updates
9.15.6 Novartis AG Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cell and Gene Therapy Industry Chain
10.2 Cell and Gene Therapy Upstream Analysis
10.3 Cell and Gene Therapy Midstream Analysis
10.4 Cell and Gene Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Cell and Gene Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Cell and Gene Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Cell and Gene Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Cell and Gene Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Cell and Gene Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy Players in 2025
Table 12. World Cell and Gene Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Cell and Gene Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy Players
Table 15. Cell and Gene Therapy Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Cell and Gene Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy Revenue Market Share (2021-2026)
Table 23. China Based Cell and Gene Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based Cell and Gene Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy Revenue Market Share (2021-2026)
Table 29. World Cell and Gene Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Cell and Gene Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Cell and Gene Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World Cell and Gene Therapy Market Size by Cell Source, (USD Million), 2021 & 2025 & 2032
Table 33. World Cell and Gene Therapy Market Size Value by Cell Source (2021-2026) & (USD Million)
Table 34. World Cell and Gene Therapy Market Size by Cell Source (2027-2032) & (USD Million)
Table 35. World Cell and Gene Therapy Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 36. World Cell and Gene Therapy Market Size Value by Technology (2021-2026) & (USD Million)
Table 37. World Cell and Gene Therapy Market Size by Technology (2027-2032) & (USD Million)
Table 38. World Cell and Gene Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Cell and Gene Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World Cell and Gene Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Amgen Inc. Major Business
Table 43. Amgen Inc. Cell and Gene Therapy Product and Services
Table 44. Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Amgen Inc. Recent Developments/Updates
Table 46. Amgen Inc. Competitive Strengths & Weaknesses
Table 47. Dendreon Pharmaceuticals LLC. Basic Information, Manufacturing Base and Competitors
Table 48. Dendreon Pharmaceuticals LLC. Major Business
Table 49. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Services
Table 50. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Dendreon Pharmaceuticals LLC. Recent Developments/Updates
Table 52. Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
Table 53. Fibrocell Science, Inc Basic Information, Manufacturing Base and Competitors
Table 54. Fibrocell Science, Inc Major Business
Table 55. Fibrocell Science, Inc Cell and Gene Therapy Product and Services
Table 56. Fibrocell Science, Inc Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Fibrocell Science, Inc Recent Developments/Updates
Table 58. Fibrocell Science, Inc Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Manufacturing Base and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Cell and Gene Therapy Product and Services
Table 62. Lonza Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Charles River Laboratories Major Business
Table 67. Charles River Laboratories Cell and Gene Therapy Product and Services
Table 68. Charles River Laboratories Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Charles River Laboratories Recent Developments/Updates
Table 70. Charles River Laboratories Competitive Strengths & Weaknesses
Table 71. Cytiva Basic Information, Manufacturing Base and Competitors
Table 72. Cytiva Major Business
Table 73. Cytiva Cell and Gene Therapy Product and Services
Table 74. Cytiva Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Cytiva Recent Developments/Updates
Table 76. Cytiva Competitive Strengths & Weaknesses
Table 77. Catalent Biologics Basic Information, Manufacturing Base and Competitors
Table 78. Catalent Biologics Major Business
Table 79. Catalent Biologics Cell and Gene Therapy Product and Services
Table 80. Catalent Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent Biologics Recent Developments/Updates
Table 82. Catalent Biologics Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Made Scientific Basic Information, Manufacturing Base and Competitors
Table 90. Made Scientific Major Business
Table 91. Made Scientific Cell and Gene Therapy Product and Services
Table 92. Made Scientific Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Made Scientific Recent Developments/Updates
Table 94. Made Scientific Competitive Strengths & Weaknesses
Table 95. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 96. AGC Biologics Major Business
Table 97. AGC Biologics Cell and Gene Therapy Product and Services
Table 98. AGC Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. AGC Biologics Recent Developments/Updates
Table 100. AGC Biologics Competitive Strengths & Weaknesses
Table 101. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 102. Pfizer CentreOne Major Business
Table 103. Pfizer CentreOne Cell and Gene Therapy Product and Services
Table 104. Pfizer CentreOne Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Pfizer CentreOne Recent Developments/Updates
Table 106. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 107. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 108. Samsung Biologics Major Business
Table 109. Samsung Biologics Cell and Gene Therapy Product and Services
Table 110. Samsung Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Samsung Biologics Recent Developments/Updates
Table 112. Samsung Biologics Competitive Strengths & Weaknesses
Table 113. Kite Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Kite Pharma, Inc. Major Business
Table 115. Kite Pharma, Inc. Cell and Gene Therapy Product and Services
Table 116. Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Kite Pharma, Inc. Recent Developments/Updates
Table 118. Kite Pharma, Inc. Competitive Strengths & Weaknesses
Table 119. Kolon TissueGene, Inc. Basic Information, Manufacturing Base and Competitors
Table 120. Kolon TissueGene, Inc. Major Business
Table 121. Kolon TissueGene, Inc. Cell and Gene Therapy Product and Services
Table 122. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Kolon TissueGene, Inc. Recent Developments/Updates
Table 124. Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
Table 125. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 126. Novartis AG Major Business
Table 127. Novartis AG Cell and Gene Therapy Product and Services
Table 128. Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Novartis AG Recent Developments/Updates
Table 130. Novartis AG Competitive Strengths & Weaknesses
Table 131. Global Key Players of Cell and Gene Therapy Upstream (Raw Materials)
Table 132. Global Cell and Gene Therapy Typical Customers
Table 1. World Cell and Gene Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Cell and Gene Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Cell and Gene Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Cell and Gene Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Cell and Gene Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy Players in 2025
Table 12. World Cell and Gene Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Cell and Gene Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy Players
Table 15. Cell and Gene Therapy Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Cell and Gene Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy Revenue Market Share (2021-2026)
Table 23. China Based Cell and Gene Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based Cell and Gene Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy Revenue Market Share (2021-2026)
Table 29. World Cell and Gene Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Cell and Gene Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Cell and Gene Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World Cell and Gene Therapy Market Size by Cell Source, (USD Million), 2021 & 2025 & 2032
Table 33. World Cell and Gene Therapy Market Size Value by Cell Source (2021-2026) & (USD Million)
Table 34. World Cell and Gene Therapy Market Size by Cell Source (2027-2032) & (USD Million)
Table 35. World Cell and Gene Therapy Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 36. World Cell and Gene Therapy Market Size Value by Technology (2021-2026) & (USD Million)
Table 37. World Cell and Gene Therapy Market Size by Technology (2027-2032) & (USD Million)
Table 38. World Cell and Gene Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Cell and Gene Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World Cell and Gene Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Amgen Inc. Major Business
Table 43. Amgen Inc. Cell and Gene Therapy Product and Services
Table 44. Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Amgen Inc. Recent Developments/Updates
Table 46. Amgen Inc. Competitive Strengths & Weaknesses
Table 47. Dendreon Pharmaceuticals LLC. Basic Information, Manufacturing Base and Competitors
Table 48. Dendreon Pharmaceuticals LLC. Major Business
Table 49. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Services
Table 50. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Dendreon Pharmaceuticals LLC. Recent Developments/Updates
Table 52. Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
Table 53. Fibrocell Science, Inc Basic Information, Manufacturing Base and Competitors
Table 54. Fibrocell Science, Inc Major Business
Table 55. Fibrocell Science, Inc Cell and Gene Therapy Product and Services
Table 56. Fibrocell Science, Inc Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Fibrocell Science, Inc Recent Developments/Updates
Table 58. Fibrocell Science, Inc Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Manufacturing Base and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Cell and Gene Therapy Product and Services
Table 62. Lonza Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Charles River Laboratories Major Business
Table 67. Charles River Laboratories Cell and Gene Therapy Product and Services
Table 68. Charles River Laboratories Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Charles River Laboratories Recent Developments/Updates
Table 70. Charles River Laboratories Competitive Strengths & Weaknesses
Table 71. Cytiva Basic Information, Manufacturing Base and Competitors
Table 72. Cytiva Major Business
Table 73. Cytiva Cell and Gene Therapy Product and Services
Table 74. Cytiva Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Cytiva Recent Developments/Updates
Table 76. Cytiva Competitive Strengths & Weaknesses
Table 77. Catalent Biologics Basic Information, Manufacturing Base and Competitors
Table 78. Catalent Biologics Major Business
Table 79. Catalent Biologics Cell and Gene Therapy Product and Services
Table 80. Catalent Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent Biologics Recent Developments/Updates
Table 82. Catalent Biologics Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Made Scientific Basic Information, Manufacturing Base and Competitors
Table 90. Made Scientific Major Business
Table 91. Made Scientific Cell and Gene Therapy Product and Services
Table 92. Made Scientific Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Made Scientific Recent Developments/Updates
Table 94. Made Scientific Competitive Strengths & Weaknesses
Table 95. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 96. AGC Biologics Major Business
Table 97. AGC Biologics Cell and Gene Therapy Product and Services
Table 98. AGC Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. AGC Biologics Recent Developments/Updates
Table 100. AGC Biologics Competitive Strengths & Weaknesses
Table 101. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 102. Pfizer CentreOne Major Business
Table 103. Pfizer CentreOne Cell and Gene Therapy Product and Services
Table 104. Pfizer CentreOne Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Pfizer CentreOne Recent Developments/Updates
Table 106. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 107. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 108. Samsung Biologics Major Business
Table 109. Samsung Biologics Cell and Gene Therapy Product and Services
Table 110. Samsung Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Samsung Biologics Recent Developments/Updates
Table 112. Samsung Biologics Competitive Strengths & Weaknesses
Table 113. Kite Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Kite Pharma, Inc. Major Business
Table 115. Kite Pharma, Inc. Cell and Gene Therapy Product and Services
Table 116. Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Kite Pharma, Inc. Recent Developments/Updates
Table 118. Kite Pharma, Inc. Competitive Strengths & Weaknesses
Table 119. Kolon TissueGene, Inc. Basic Information, Manufacturing Base and Competitors
Table 120. Kolon TissueGene, Inc. Major Business
Table 121. Kolon TissueGene, Inc. Cell and Gene Therapy Product and Services
Table 122. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Kolon TissueGene, Inc. Recent Developments/Updates
Table 124. Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
Table 125. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 126. Novartis AG Major Business
Table 127. Novartis AG Cell and Gene Therapy Product and Services
Table 128. Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Novartis AG Recent Developments/Updates
Table 130. Novartis AG Competitive Strengths & Weaknesses
Table 131. Global Key Players of Cell and Gene Therapy Upstream (Raw Materials)
Table 132. Global Cell and Gene Therapy Typical Customers
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Picture
Figure 2. World Cell and Gene Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cell and Gene Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World Cell and Gene Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Cell and Gene Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 13. Cell and Gene Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World Cell and Gene Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Markets in 2025
Figure 27. United States VS China: Cell and Gene Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cell and Gene Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Cell and Gene Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Cell and Gene Therapy Market Size Market Share by Type in 2025
Figure 31. Rare Diseases
Figure 32. Oncology
Figure 33. Hematology
Figure 34. Cardiovascular
Figure 35. Ophthalmology
Figure 36. Neurology
Figure 37. Others
Figure 38. Others
Figure 39. World Cell and Gene Therapy Market Size Market Share by Type (2021-2032)
Figure 40. World Cell and Gene Therapy Market Size by Cell Source, (USD Million), 2021 & 2025 & 2032
Figure 41. World Cell and Gene Therapy Market Size Market Share by Cell Source in 2025
Figure 42. Autologous Cell Therapy
Figure 43. Universal Cell Therapy
Figure 44. Xenogeneic Cell Therapy
Figure 45. World Cell and Gene Therapy Market Size Market Share by Cell Source (2021-2032)
Figure 46. World Cell and Gene Therapy Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 47. World Cell and Gene Therapy Market Size Market Share by Technology in 2025
Figure 48. Viral Vector Delivery
Figure 49. Non-viral Vector Delivery
Figure 50. Gene Editing Technology
Figure 51. Others
Figure 52. World Cell and Gene Therapy Market Size Market Share by Technology (2021-2032)
Figure 53. World Cell and Gene Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Cell and Gene Therapy Market Size Market Share by Application in 2025
Figure 55. Pharmaceutical and Biotechnology Companies
Figure 56. Research and Academic Institutions
Figure 57. Contract Research Organizations (CROs)
Figure 58. Hospital
Figure 59. Others
Figure 60. World Cell and Gene Therapy Market Size Market Share by Application (2021-2032)
Figure 61. Cell and Gene Therapy Industrial Chain
Figure 62. Methodology
Figure 63. Research Process and Data Source
Figure 1. Cell and Gene Therapy Picture
Figure 2. World Cell and Gene Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cell and Gene Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World Cell and Gene Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Cell and Gene Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy Revenue (2021-2032) & (USD Million)
Figure 13. Cell and Gene Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World Cell and Gene Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India Cell and Gene Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Markets in 2025
Figure 27. United States VS China: Cell and Gene Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cell and Gene Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Cell and Gene Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Cell and Gene Therapy Market Size Market Share by Type in 2025
Figure 31. Rare Diseases
Figure 32. Oncology
Figure 33. Hematology
Figure 34. Cardiovascular
Figure 35. Ophthalmology
Figure 36. Neurology
Figure 37. Others
Figure 38. Others
Figure 39. World Cell and Gene Therapy Market Size Market Share by Type (2021-2032)
Figure 40. World Cell and Gene Therapy Market Size by Cell Source, (USD Million), 2021 & 2025 & 2032
Figure 41. World Cell and Gene Therapy Market Size Market Share by Cell Source in 2025
Figure 42. Autologous Cell Therapy
Figure 43. Universal Cell Therapy
Figure 44. Xenogeneic Cell Therapy
Figure 45. World Cell and Gene Therapy Market Size Market Share by Cell Source (2021-2032)
Figure 46. World Cell and Gene Therapy Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 47. World Cell and Gene Therapy Market Size Market Share by Technology in 2025
Figure 48. Viral Vector Delivery
Figure 49. Non-viral Vector Delivery
Figure 50. Gene Editing Technology
Figure 51. Others
Figure 52. World Cell and Gene Therapy Market Size Market Share by Technology (2021-2032)
Figure 53. World Cell and Gene Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Cell and Gene Therapy Market Size Market Share by Application in 2025
Figure 55. Pharmaceutical and Biotechnology Companies
Figure 56. Research and Academic Institutions
Figure 57. Contract Research Organizations (CROs)
Figure 58. Hospital
Figure 59. Others
Figure 60. World Cell and Gene Therapy Market Size Market Share by Application (2021-2032)
Figure 61. Cell and Gene Therapy Industrial Chain
Figure 62. Methodology
Figure 63. Research Process and Data Source
